Ana Salazar Modela Tu Cuerpo recalls Lipofit Extreme Fat Burner 2.0 after FDA finds undeclared fluoxetine and DNP
Ana Salazar Modela Tu Cuerpo Inc. announced a voluntary nationwide recall of its Lipofit Extreme Fat Burner 2.0 on August 27, 2026, targeting the lot with expiration in September 2027.
FDA laboratory analysis detected undeclared fluoxetine in the daytime tablets and undeclared 2,4-dinitrophenol (DNP) in the nighttime tablets.
Fluoxetine is a prescription antidepressant, while DNP is a toxic chemical used industrially and not approved for weight-loss or any dietary supplement use.
Because the product contains these unapproved ingredients, it is considered an unapproved new drug and is being recalled to the consumer level to protect public health.
This writeup was produced by pharmadog from original reporting by fda recalls.
Original headline: “Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)”
read at fda recalls ↗
comments(0)
5-min edit window · permanent after that